Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Butcher

Showing results (911-920 of 988) with videos related to

Pageof 99
Sort By:
Journal of Clinical Epidemiology|May 5, 2023
Paper I: Heterogeneous use of registry data for participant identification and primary outcome ascertainment is found in registry-based randomized controlled trials: A scoping reviewAmi Baba, Joanne Tay, Adrian Sammy, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2010
M3-muscarinic receptor promotes insulin release via receptor phosphorylation/arrestin-dependent activation of protein kinase D1Kok Choi Kong, Adrian J Butcher, Phillip McWilliams, et al.
Antiviral Research|February 22, 2024
The α-dystroglycan N-terminus is a broad-spectrum antiviral agent against SARS-CoV-2 and enveloped virusesMaria Giulia Bigotti, Katja Klein, Esther S Gan, et al.
Journal of Clinical Epidemiology|May 5, 2023
Paper II: thematic framework analysis of registry-based randomized controlled trials provided insights for designing trial ready registriesKarolin R Krause, Joanne Tay, William A Douglas, et al.
BMJ Open|October 11, 2022
Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATEAnthony Muchai Manyara, Philippa Davies, Derek Stewart, et al.
Biochimica Et Biophysica Acta|September 25, 2016
Influenza virus NS1 protein binds cellular DNA to block transcription of antiviral genesMaria Anastasina, Nicolas Le May, Andrii Bugai, et al.
Scientific Reports|September 23, 2017
Strain-dependent neutralization reveals antigenic variation of human parechovirus 3Eveliina Karelehto, Sabine van der Sanden, James A Geraets, et al.
Journal of Biomedical Science|March 27, 2026
Coxsackie B1 virus-like particle that lacks VP4 protein demonstrates improved vaccine scalability, stability and immunogenicitySaana Soppela, Henna-Maarit Kyröläinen, Alesia Levanova, et al.
Biomaterials Science|April 29, 2024
Lipid sulfoxide polymers as potential inhalable drug delivery platforms with differential albumin binding affinityGayathri R Ediriweera, Neville J Butcher, Ashok Kothapalli, et al.
The Journal of Biological Chemistry|January 31, 2016
An Antibody Biosensor Establishes the Activation of the M1 Muscarinic Acetylcholine Receptor during Learning and MemoryAdrian J Butcher, Sophie J Bradley, Rudi Prihandoko, et al.
Pageof 99

Showing results (911-920 of 988) with videos related to

Sort By:
Pageof 99
Journal of Clinical Epidemiology|May 5, 2023
Paper I: Heterogeneous use of registry data for participant identification and primary outcome ascertainment is found in registry-based randomized controlled trials: A scoping reviewAmi Baba, Joanne Tay, Adrian Sammy, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2010
M3-muscarinic receptor promotes insulin release via receptor phosphorylation/arrestin-dependent activation of protein kinase D1Kok Choi Kong, Adrian J Butcher, Phillip McWilliams, et al.
Antiviral Research|February 22, 2024
The α-dystroglycan N-terminus is a broad-spectrum antiviral agent against SARS-CoV-2 and enveloped virusesMaria Giulia Bigotti, Katja Klein, Esther S Gan, et al.
Journal of Clinical Epidemiology|May 5, 2023
Paper II: thematic framework analysis of registry-based randomized controlled trials provided insights for designing trial ready registriesKarolin R Krause, Joanne Tay, William A Douglas, et al.
BMJ Open|October 11, 2022
Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATEAnthony Muchai Manyara, Philippa Davies, Derek Stewart, et al.
Biochimica Et Biophysica Acta|September 25, 2016
Influenza virus NS1 protein binds cellular DNA to block transcription of antiviral genesMaria Anastasina, Nicolas Le May, Andrii Bugai, et al.
Scientific Reports|September 23, 2017
Strain-dependent neutralization reveals antigenic variation of human parechovirus 3Eveliina Karelehto, Sabine van der Sanden, James A Geraets, et al.
Journal of Biomedical Science|March 27, 2026
Coxsackie B1 virus-like particle that lacks VP4 protein demonstrates improved vaccine scalability, stability and immunogenicitySaana Soppela, Henna-Maarit Kyröläinen, Alesia Levanova, et al.
Biomaterials Science|April 29, 2024
Lipid sulfoxide polymers as potential inhalable drug delivery platforms with differential albumin binding affinityGayathri R Ediriweera, Neville J Butcher, Ashok Kothapalli, et al.
The Journal of Biological Chemistry|January 31, 2016
An Antibody Biosensor Establishes the Activation of the M1 Muscarinic Acetylcholine Receptor during Learning and MemoryAdrian J Butcher, Sophie J Bradley, Rudi Prihandoko, et al.
Pageof 99